Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company
A wholly owned subsidiary of Eli Lilly and Company.
- Location
- —
- Roles tracked
- 0
- In pipeline
- 0
- Tracking since
- —
At a glance
You're tracking 0 roles at Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company. Track a role to start building momentum here.
Company intel
From the job board · LinkedIn data via posting sync- Industry
- Biotechnology Research
- Company size
- 153 people
- Founded
- 2021
- Type
- Public Company
- Total funding
- $1.1B
Centessa Pharmaceuticals plc, a wholly owned subsidiary of Eli Lilly and Company, is developing a portfolio of orexin receptor 2 (OX2R) agonists for the potential treatment of sleep-wake and other neuroscience disorders.
Clinical Trials
Biotechnology
Life Science
Pharmaceutical
Open roles at Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company
- CMC Technical Writer (Contract) Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company · Boston, Massachusetts, United States · $250K–$291K/yr
- Manager, Product Quality Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company · Boston, Massachusetts, United States · $105K–$150K/yr
- Associate Project Manager, Drug Development Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company · Boston, Massachusetts, United States · $80K–$130K/yr
